Comparative Pharmacology
Head-to-head clinical analysis: OTOBIOTIC versus PEDIOTIC.
Peer-Reviewed Evidence
Head-to-head clinical analysis: OTOBIOTIC versus PEDIOTIC.
OTOBIOTIC vs PEDIOTIC
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Otobiotic is a fixed-dose combination of ciprofloxacin (a fluoroquinolone antibiotic) and fluocinolone acetonide (a corticosteroid). Ciprofloxacin inhibits bacterial DNA gyrase and topoisomerase IV, leading to bacterial DNA replication inhibition and cell death. Fluocinolone acetonide suppresses inflammation by binding to glucocorticoid receptors, modulating gene expression, and reducing inflammatory mediators.
PEDIOTIC contains hydrocortisone, neomycin, and polymyxin B. Neomycin and polymyxin B are antibiotics that inhibit bacterial protein synthesis and disrupt bacterial cell membrane integrity, respectively. Hydrocortisone is a corticosteroid that suppresses inflammation by inhibiting phospholipase A2, reducing prostaglandin and leukotriene synthesis.
Adults and children: 3-4 drops into the affected ear twice daily for 7 days. Shake well before use.
Instill 4 drops into the affected ear(s) twice daily for 7-10 days.
None Documented
None Documented
Terminal elimination half-life: 2-3 hours in patients with normal renal function; prolonged to 24-48 hours in anuria.
Not established for topical otic use; systemic absorption is minimal. If absorbed, terminal half-life of dexamethasone is approximately 3-4 hours.
Renal elimination of unchanged drug: 60-80%; biliary/fecal elimination: 10-20%; the remainder undergoes hepatic metabolism.
Renal elimination of absorbed drug (primarily unchanged) accounts for <10% of topically applied dose; fecal/biliary routes negligible.
Category C
Category C
Otic Antibiotic/Corticosteroid
Otic Antibiotic/Corticosteroid Combination